China Evergrande New Energy Vehicle Group Limited (EVGRF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
China Evergrande New Energy Vehicle Group Limited (EVGRF) with AI Score 60/100 (Hold). China Evergrande New Energy Vehicle Group Limited is an investment holding company focused on health management and new energy vehicles. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026China Evergrande New Energy Vehicle Group Limited (EVGRF) Healthcare & Pipeline Overview
China Evergrande New Energy Vehicle Group Limited stands at the intersection of healthcare and sustainable transportation, offering a diverse portfolio that includes health management services and new energy vehicles, positioning itself as a multifaceted player in both sectors.
Investment Thesis
China Evergrande New Energy Vehicle Group Limited presents a unique investment thesis driven by its dual focus on healthcare services and new energy vehicle production. The company's market cap of $0.01 billion and a P/E ratio of -0.14 indicate current challenges, yet its strategic initiatives in health management and new energy vehicles could unlock significant growth potential. The ongoing global shift towards sustainable practices and healthcare innovation presents a favorable backdrop for the company's expansion. Key value drivers include its diversified service offerings, potential for market share growth in the health management sector, and the increasing demand for new energy vehicles. The company's commitment to research and development in pharmaceuticals and medical technology further enhances its competitive positioning. However, investors should remain cautious of the negative profit margin of -890.5% and the gross margin of -3.8%, which highlight underlying operational challenges that need to be addressed for sustainable growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Market cap of $0.01 billion reflects the company's current valuation amidst operational challenges.
- P/E ratio of -0.14 indicates negative earnings, suggesting potential financial instability.
- Profit margin of -890.5% highlights significant operational losses that need addressing.
- Gross margin of -3.8% indicates challenges in maintaining profitability in its business segments.
- Beta of 1.12 suggests higher volatility compared to the market, reflecting investor sentiment.
Competitors & Peers
Strengths
- Diverse portfolio combining healthcare and new energy vehicle sectors.
- Established presence in the Chinese healthcare market.
- Strong potential for growth in the new energy vehicle segment.
- Commitment to research and development fostering innovation.
Weaknesses
- Negative profit margin indicating operational challenges.
- High volatility reflected in beta of 1.12.
- Limited brand recognition outside of China.
- Dependence on the domestic market for most revenue.
Catalysts
- Upcoming: Expansion of healthcare services to meet rising demand in urban areas.
- Ongoing: Development of new energy vehicles aligning with global sustainability trends.
- Upcoming: Introduction of innovative healthcare technology solutions to enhance service delivery.
- Ongoing: Strategic partnerships with healthcare organizations to broaden market reach.
- Upcoming: Launch of new medical products and services in response to consumer needs.
Risks
- Potential: Regulatory changes impacting healthcare and automotive operations.
- Ongoing: Financial instability reflected in negative profit margins.
- Potential: Competition from established players in both healthcare and new energy sectors.
- Ongoing: Economic downturns affecting consumer spending on healthcare services.
Growth Opportunities
- Growth opportunity 1: The global health management market is expected to reach $1 trillion by 2027, driven by increasing consumer awareness and demand for personalized healthcare services. China Evergrande's focus on community health management and elderly care positions it to capture a significant share of this expanding market, particularly in urban areas where healthcare access is critical.
- Growth opportunity 2: The new energy vehicle market is projected to grow at a CAGR of 22% through 2027, driven by technological advancements and regulatory support for sustainable transportation. China Evergrande's investments in smart mobility solutions and lithium-ion battery production place it in a favorable position to benefit from this growth, particularly as global demand for electric vehicles continues to rise.
- Growth opportunity 3: The increasing prevalence of chronic diseases in China presents a substantial opportunity for the company's healthcare services. By expanding its offerings in medical cosmetology and anti-aging services, China Evergrande can tap into the growing consumer demand for preventative health measures and wellness solutions, potentially increasing its revenue streams.
- Growth opportunity 4: With the rise of telemedicine and digital health solutions, China Evergrande's software services can play a crucial role in enhancing healthcare delivery. By integrating technology into its health management services, the company can improve patient engagement and outcomes, positioning itself as a leader in innovative healthcare solutions.
- Growth opportunity 5: The company's commitment to research and development in pharmaceuticals and medical equipment production presents opportunities for innovation and market differentiation. By developing proprietary technologies and products, China Evergrande can enhance its competitive advantage and drive revenue growth in both the healthcare and new energy sectors.
Opportunities
- Growing demand for health management services in aging populations.
- Expansion potential in the new energy vehicle market.
- Increasing interest in telemedicine and digital health solutions.
- Potential partnerships with government and healthcare organizations.
Threats
- Intense competition from established healthcare and automotive companies.
- Regulatory challenges in the healthcare and automotive sectors.
- Economic fluctuations impacting consumer spending on healthcare.
- Technological advancements by competitors could outpace company innovations.
Competitive Advantages
- Diversified service offerings that cater to both healthcare and sustainable transportation.
- Established brand reputation in the health management sector.
- Strategic investments in research and development for innovative solutions.
- Strong presence in the rapidly growing new energy vehicle market.
- Ability to leverage economies of scale in production and distribution.
About EVGRF
Founded in 1999, China Evergrande New Energy Vehicle Group Limited, originally known as Evergrande Health Industry Group Limited, has evolved into a prominent investment holding company headquartered in Guangzhou, China. The company operates primarily in the healthcare sector, focusing on health management services and the development of new energy vehicles. With a commitment to enhancing community health, it provides a range of services, including community health management, medical cosmetology, anti-aging services, elderly care, and rehabilitation. In addition to healthcare services, China Evergrande New Energy Vehicle Group is involved in the wholesale of home care and healthcare products, alongside software services that support healthcare delivery. The company also engages in pharmaceutical research and development, medical equipment production, and the manufacture and sale of smart mobility solutions and lithium-ion batteries. Its strategic pivot to new energy vehicles reflects a growing emphasis on sustainability and innovation in transportation, aligning with global trends towards eco-friendly solutions. This diversification not only broadens its market reach but also positions the company favorably within the rapidly evolving landscape of health management and new energy sectors.
What They Do
- Develops and sells health and living properties.
- Provides community health management services.
- Offers medical cosmetology and anti-aging services.
- Delivers elderly care and rehabilitation services.
- Wholesale of home care and healthcare products.
- Engages in pharmaceutical research and development.
- Produces medical equipment and smart mobility solutions.
- Manufactures and sells lithium-ion batteries.
Business Model
- Revenue generated through health management services and community health programs.
- Sales from new energy vehicles and related products.
- Wholesale distribution of healthcare products and medical equipment.
- Software services that support healthcare delivery and management.
- Research and development initiatives that lead to innovative healthcare solutions.
Industry Context
The healthcare sector, particularly in medical care facilities, is experiencing significant growth driven by an aging population and increasing demand for health management services. The global market for healthcare services is projected to expand as consumers seek comprehensive care solutions. Concurrently, the new energy vehicle market is witnessing rapid advancements, with a projected CAGR of 22% through 2027, driven by technological innovations and government incentives for sustainable transportation. China Evergrande New Energy Vehicle Group Limited is strategically positioned within this competitive landscape, leveraging its dual focus on health management and new energy vehicles to capitalize on emerging market trends.
Key Customers
- Individuals seeking health management and wellness services.
- Elderly patients requiring rehabilitation and care.
- Healthcare facilities needing medical equipment and products.
- Consumers interested in new energy vehicles and smart mobility solutions.
- Government and private organizations looking for community health management partnerships.
Financials
Chart & Info
China Evergrande New Energy Vehicle Group Limited (EVGRF) stock price: Price data unavailable
Latest News
-
Hong Kong Stocks End The Week In A Rout As China's Central Bank Pumps $100 Billion Into Banking System Ahead Of Long Weekend
benzinga · Oct 20, 2023
-
China's Largest Property Developer Misses Its First Bond Payment, While Another Heads To Court With Creditors Next Week
benzinga · Oct 18, 2023
-
Hong Kong Stocks Rally As Sovereign Bank Buy-Up Overshadows Climb In Negative Mortgages
benzinga · Oct 12, 2023
-
Some Hong Kong Stocks Are Soaring Again On Chinese Whispers About A Profitable Bailout
benzinga · Oct 11, 2023
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EVGRF.
Price Targets
Wall Street price target analysis for EVGRF.
MoonshotScore
What does this score mean?
The MoonshotScore rates EVGRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Hong Kong Stocks End The Week In A Rout As China's Central Bank Pumps $100 Billion Into Banking System Ahead Of Long Weekend
China's Largest Property Developer Misses Its First Bond Payment, While Another Heads To Court With Creditors Next Week
Hong Kong Stocks Rally As Sovereign Bank Buy-Up Overshadows Climb In Negative Mortgages
Some Hong Kong Stocks Are Soaring Again On Chinese Whispers About A Profitable Bailout
Leadership: Shawn Siu
CEO
Shawn Siu has been instrumental in guiding China Evergrande New Energy Vehicle Group Limited through its strategic transformation. With a strong background in business management and operations, he has overseen the company's expansion into new markets and sectors. Siu holds a degree in Business Administration and has extensive experience in the healthcare and automotive industries, which positions him well to lead the company in its dual focus on health management and new energy vehicles.
Track Record: Under Shawn Siu's leadership, the company has diversified its offerings and strengthened its market position. His strategic decisions have led to increased investments in research and development, positioning China Evergrande to capitalize on emerging trends in both healthcare and sustainable transportation.
EVGRF OTC Market Information
The OTC Other tier includes companies that do not meet the listing requirements of major exchanges like NYSE or NASDAQ. These stocks may have lower liquidity and higher volatility, making them riskier investments. Companies in this tier often provide less financial transparency, which can be a concern for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures may result in a lack of transparency.
- Higher volatility and lower liquidity compared to stocks on major exchanges.
- Potential for significant price fluctuations based on market sentiment.
- Regulatory scrutiny may impact operations and stock performance.
- Verify the company's financial health through available reports.
- Assess the management team's experience and track record.
- Evaluate the competitive landscape and market positioning.
- Understand the regulatory environment affecting the business.
- Monitor industry trends that may impact growth prospects.
- Established history since 1999 in the healthcare sector.
- Diverse product offerings across healthcare and automotive sectors.
- Affiliation with China Evergrande Group enhances credibility.
- Engagement in research and development indicates commitment to innovation.
EVGRF Healthcare Stock FAQ
What does China Evergrande New Energy Vehicle Group Limited do?
China Evergrande New Energy Vehicle Group Limited operates as a health management company, providing a range of services including community health management, medical cosmetology, and elderly care. Additionally, the company is involved in the development and sale of new energy vehicles and related technologies, positioning itself at the intersection of healthcare and sustainable transportation.
What do analysts say about EVGRF stock?
Analysts have mixed views on EVGRF stock, primarily due to its negative earnings and operational challenges. Key valuation metrics indicate financial instability, with a P/E ratio of -0.14 and a profit margin of -890.5%. Growth considerations focus on the company's potential in the healthcare and new energy vehicle markets, though caution is advised given its current financial state.
What are the main risks for EVGRF?
Key risks for China Evergrande New Energy Vehicle Group Limited include regulatory challenges that could impact its operations in both healthcare and automotive sectors. Additionally, the company's financial instability, reflected in its negative profit margins, poses a significant risk. Competition from established players in the healthcare and new energy vehicle markets further adds to the uncertainty surrounding the company's growth prospects.
What are the key factors to evaluate for EVGRF?
China Evergrande New Energy Vehicle Group Limited (EVGRF) currently holds an AI score of 60/100, indicating moderate score. Key strength: Diverse portfolio combining healthcare and new energy vehicle sectors.. Primary risk to monitor: Potential: Regulatory changes impacting healthcare and automotive operations.. This is not financial advice.
How frequently does EVGRF data refresh on this page?
EVGRF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EVGRF's recent stock price performance?
Recent price movement in China Evergrande New Energy Vehicle Group Limited (EVGRF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse portfolio combining healthcare and new energy vehicle sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EVGRF overvalued or undervalued right now?
Determining whether China Evergrande New Energy Vehicle Group Limited (EVGRF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EVGRF?
Before investing in China Evergrande New Energy Vehicle Group Limited (EVGRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information; operational challenges may impact future performance.